CIK 0001707502 · Non-accelerated filer<br>Smaller reporting company
Solid Biosciences Inc.
Sign in to watch- Ticker
- SLDB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 900943402
- Phone
- 617-337-4680
- Business address
- 500 RUTHERFORD AVENUE, 3RD FLOOR, CHARLESTOWN, MA, 02129
- Former names
- Solid Biosciences, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,582
- in 1 filing, $25K under 10b5-1 plans
Net −$24,582. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-29 | Cumbo Alexander President and CEO | Grant or award · Employee Stock Option (Right to Buy) 10b5-1 | +509,850 | 509,850 | ||
| 2026-01-29 | Cumbo Alexander President and CEO | Grant or award · Restricted Stock Units 10b5-1 | +254,900 | 254,900 | ||
| 2026-01-29 | Hanrahan Jessie Chief Regulatory Officer | Option exercise 10b5-1 | +54,925 | 81,585 | ||
| 2026-01-29 | Hanrahan Jessie Chief Regulatory Officer | Option exercise · Performance Stock Units 10b5-1 | −54,925 | 0 | ||
| 2026-01-29 | Hanrahan Jessie Chief Regulatory Officer | Grant or award · Employee Stock Option (Right to Buy) 10b5-1 | +190,000 | 190,000 | ||
| 2026-01-29 | Hanrahan Jessie Chief Regulatory Officer | Grant or award · Restricted Stock Units 10b5-1 | +95,000 | 95,000 | ||
| 2026-01-29 | Brooks Gabriel Chief Medical Officer | Option exercise 10b5-1 | +58,847 | 96,818 | ||
| 2026-01-29 | Brooks Gabriel Chief Medical Officer | Option exercise · Performance Stock Units 10b5-1 | −58,847 | 0 | ||
| 2026-01-29 | Brooks Gabriel Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) 10b5-1 | +207,450 | 207,450 | ||
| 2026-01-29 | Brooks Gabriel Chief Medical Officer | Grant or award · Restricted Stock Units 10b5-1 | +103,750 | 103,750 | ||
| 2026-01-29 | Howton David T Chief Operating Officer | Option exercise 10b5-1 | +79,341 | 112,249 | ||
| 2026-01-29 | Howton David T Chief Operating Officer | Option exercise · Performance Stock Units 10b5-1 | −79,341 | 0 | ||
| 2026-01-29 | Howton David T Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) 10b5-1 | +210,200 | 210,200 | ||
| 2026-01-29 | Howton David T Chief Operating Officer | Grant or award · Restricted Stock Units 10b5-1 | +105,100 | 105,100 | ||
| 2026-01-29 | Herzich Paul Chief Technology Officer | Option exercise 10b5-1 | +54,925 | 81,547 | ||
| 2026-01-29 | Herzich Paul Chief Technology Officer | Option exercise · Performance Stock Units 10b5-1 | −54,925 | 0 | ||
| 2026-01-29 | Herzich Paul Chief Technology Officer | Grant or award · Employee Stock Option (Right to Buy) 10b5-1 | +170,000 | 170,000 | ||
| 2026-01-29 | Herzich Paul Chief Technology Officer | Grant or award · Restricted Stock Units 10b5-1 | +85,000 | 85,000 | ||
| 2026-01-29 | Ganot Ilan Director | Grant or award · Employee Stock Option (Right to Buy) 10b5-1 | +70,900 | 70,900 | ||
| 2026-01-29 | Ganot Ilan Director | Grant or award · Restricted Stock Units 10b5-1 | +35,450 | 35,450 |
Page 5 of 12 · 223 trades